Moderna COVID-19 Vaccine
An mRNA vaccine, noted for being under emergency use authorization and initially dosed four weeks apart, with dose containing 100 micrograms of mRNA, related to higher myocarditis risk.
Common Themes
Videos Mentioning Moderna COVID-19 Vaccine
COVID Part 2: Masks, long COVID, boosters, mandates, treatments, and more
Peter Attia MD
An mRNA vaccine, noted for being under emergency use authorization and initially dosed four weeks apart, with dose containing 100 micrograms of mRNA, related to higher myocarditis risk.
COVID-19: Current state of affairs, Omicron, and a search for the end game | Peter Attia, M.D.
Peter Attia MD
An mRNA vaccine discussed for its benefits and risks, particularly concerning a higher incidence of myocarditis in young people compared to the Pfizer vaccine.
#159-Peter Hotez MD, PhD.: The anti-vaccine movement, causes of autism, & COVID-19 vaccine update
Peter Attia MD
mRNA vaccine with high efficacy, potentially requiring a third dose as a booster, and showing declines in neutralizing antibodies against South African/Brazilian variants in in vitro studies.
Jamie Metzl: Lab Leak Theory | Lex Fridman Podcast #247
Lex Fridman
An mRNA vaccine for COVID-19, developed rapidly and praised for its effectiveness, highlighting the success of public-private partnerships in vaccine development.
Tyler Cowen: Economic Growth & the Fight Against Conformity & Mediocrity | Lex Fridman Podcast #174
Lex Fridman
Described as a vaccine developed by an Armenian immigrant through Lebanon and Canada to the Boston/Cambridge area, highlighting international talent.
E51: Supply Chain Shortages, Inflation, DeSantis, Ted Sarandos Netflix Memo, Cancel Culture, Fan Q&A
All-In Podcast
COVID-19 vaccine, discussed in the context of half-dose booster shots and the FDA's changing recommendations.
A Contagion of Bad Ideas: A Conversation with Eric Topol (Episode #256)
Sam Harris
Another mRNA vaccine discussed, noted for its high efficacy in initial trials and continued effectiveness in real-world data.